University of Utah at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Utah brings 9 presentations to ASH 2026 in New Orleans. Its program covers blood clots, transplant and myeloma care. Research looks at extended anticoagulation after a first unprovoked clot, electronic clot risk assessment, and sessions on anti-BCMA bispecific antibodies.
| Organization | ASH 2026 Attendance |
|---|---|
University of Utah Salt Lake City, UT | |
Public research university in Salt Lake City with the University of Utah Health system and Huntsman Cancer Institute. | Symposium Fri Dec 11 7:00am–10:00am Anti-BCMA Bispecific Antibodies in Multiple Myeloma: From Biology to Real-World Implementation Bispecific antibodies targeting B-cell maturation antigen in myeloma, from mechanism and resistance to trial data, outpatient dosing, and infection prevention. Talk Fri Dec 11 4:24pm–5:23pm Symposium Fri Dec 11 7:00pm–10:00pm Clinical Turning Points: Decisions That Shape Care Across the Spectrum of Systemic Mastocytosis Recognizing the full symptom burden of non-advanced systemic mastocytosis, judging disease control, and deciding when to escalate to disease-directed therapy. Oral Sat Dec 12 9:30am–11:00am Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Talk Mon Dec 14 2:45pm–4:00pm The Impact of Perinatal Inflammation on HSC Fitness How fetal blood stem and progenitor cells respond to inflammation before birth, leaving lasting marks on the immune system after birth. Oral Mon Dec 14 4:30pm–6:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Session |
Find decision makers at University of Utah
Tell us what you sell and we’ll find the people at University of Utah most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction